Fig. 4: Associations between 11 proteins and incident breast cancer stratified by tumor ER status in the TZL cohort study (ER negative: 20 cases; ER positive: 69 cases). | npj Precision Oncology

Fig. 4: Associations between 11 proteins and incident breast cancer stratified by tumor ER status in the TZL cohort study (ER negative: 20 cases; ER positive: 69 cases).

From: Association of circulating immuno-oncology biomarkers with breast cancer risk: insights from two prospective cohorts

Fig. 4

Adjusted for age at menarche, menopausal status, number of births, BMI and height. The proteins analyzed include: CASP8 (A), CCL4 (B), LAP TGF-β1 (C), HGF (D), CCL23 (E), MMP7 (F), FASLG (G), TEK (H), ARG1 (I), CXCL11 (J), and CCL3 (K). Statistical significance is denoted as follows: *P < 0.05, **P < 0.01, and ***P < 0.001.

Back to article page